Evaluation of Costa Rica’s Drug Policy (2005-2025)
This study is part of the COPOLAD III Programme, within Working Group 1.4 on Drug Policy Evaluation, in close collaboration ...
This study is part of the COPOLAD III Programme, within Working Group 1.4 on Drug Policy Evaluation, in close collaboration ...
On Thursday, 13 November, the Costa Rican Drug Institute (ICD) presented the main findings and recommendations on the evaluation of ...
When our collaboration with the European Union Drugs Agency (EUDA) wrapped up in March this year, it marked the end ...
Implementing wastewater studies in Latin America and the Caribbean is the focus of an EUDA technical meeting kicking off from ...
This week professionals from different Cuban organisations have participated in a first workshop on the role of a National Drug ...
This week, the European Drugs Agency (EUDA), through the COPOLAD III Programme, is promoting oline training sessions focused on strengthening ...
On 20 March, the EMCDDA will organise an online capacity-building workshop on Early Warning Systems (EWS), in the framework of ...
From October 23-27, 2023, the European Monitoring Centre for Drugs (EMCDDA), in the framework of COPOLAD, organized, together with the ...
What institutional, human and financial resources do the National Drug Observatories have at their disposal to consolidate their national research ...
The international meeting of National Drug Observatories (NDOs) held within the framework of the emblematic EMCDDA, the European Monitoring Centre ...
COPOLAD is a consortium formed by:


Collaborating partners:


© COPOLAD. Programa de Cooperación entre América Latina, el Caribe y la Unión Europea en Políticas sobre Drogas.